Provided By GlobeNewswire
Last update: Sep 22, 2025
GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Douglas Larson, Chief Financial Officer of Beyond Air, will participate in the ROTH 4th Annual Healthcare Opportunities Conference, which is being held on Thursday, October 9, 2025, in New York, NY.
Read more at globenewswire.com1.23
-0.12 (-8.89%)
Find more stocks in the Stock Screener


